Search research articles
Contact Us
Filters
Showing results (61-70 of 80) with videos related to
Page
of 8
Sort By:
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences
|
March 13, 2014
Long-term impact of behavioral weight loss intervention on cognitive function
Mark A Espeland, Stephen R Rapp, George A Bray, et al.
Journal of Hospital Medicine
|
October 15, 2010
A comparison study of continuous insulin infusion protocols in the medical intensive care unit: computer-guided vs. standard column-based algorithms
Christopher A Newton, Dawn Smiley, Bruce W Bode, et al.
The Journal of Clinical Endocrinology and Metabolism
|
November 20, 2008
The association of ENPP1 K121Q with diabetes incidence is abolished by lifestyle modification in the diabetes prevention program
Allan F Moore, Kathleen A Jablonski, Clinton C Mason, et al.
BMC Endocrine Disorders
|
July 31, 2009
Actos Now for the prevention of diabetes (ACT NOW) study
Ralph A Defronzo, Maryann Banerji, George A Bray, et al.
Circulation. Cardiovascular Genetics
|
July 18, 2013
Do genetic modifiers of high-density lipoprotein cholesterol and triglyceride levels also modify their response to a lifestyle intervention in the setting of obesity and type-2 diabetes mellitus?: The Action for Health in Diabetes (Look AHEAD) study
Gordon S Huggins, George D Papandonatos, Bahar Erar, et al.
Obesity (Silver Spring, Md.)
|
April 29, 2014
Evaluation of early weight loss thresholds for identifying nonresponders to an intensive lifestyle intervention
Jessica L Unick, Patricia E Hogan, Rebecca H Neiberg, et al.
The Journal of Sexual Medicine
|
February 5, 2009
Erectile dysfunction in type 2 diabetic men: relationship to exercise fitness and cardiovascular risk factors in the Look AHEAD trial
Raymond C Rosen, Rena R Wing, Stephen Schneider, et al.
JAMA
|
January 5, 2013
Association of an intensive lifestyle intervention with remission of type 2 diabetes
Edward W Gregg, Haiying Chen, Lynne E Wagenknecht, et al.
The Journal of Clinical Endocrinology and Metabolism
|
March 17, 2016
Diabetes Incidence and Glucose Tolerance after Termination of Pioglitazone Therapy: Results from ACT NOW
Devjit Tripathy, Dawn C Schwenke, MaryAnn Banerji, et al.
Diabetes Care
|
April 8, 2014
Baseline adiponectin levels do not influence the response to pioglitazone in ACT NOW
Devjit Tripathy, Stephen C Clement, Dawn C Schwenke, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 80) with videos related to
Sort By:
Page
of 8
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences
|
March 13, 2014
Long-term impact of behavioral weight loss intervention on cognitive function
Mark A Espeland, Stephen R Rapp, George A Bray, et al.
Journal of Hospital Medicine
|
October 15, 2010
A comparison study of continuous insulin infusion protocols in the medical intensive care unit: computer-guided vs. standard column-based algorithms
Christopher A Newton, Dawn Smiley, Bruce W Bode, et al.
The Journal of Clinical Endocrinology and Metabolism
|
November 20, 2008
The association of ENPP1 K121Q with diabetes incidence is abolished by lifestyle modification in the diabetes prevention program
Allan F Moore, Kathleen A Jablonski, Clinton C Mason, et al.
BMC Endocrine Disorders
|
July 31, 2009
Actos Now for the prevention of diabetes (ACT NOW) study
Ralph A Defronzo, Maryann Banerji, George A Bray, et al.
Circulation. Cardiovascular Genetics
|
July 18, 2013
Do genetic modifiers of high-density lipoprotein cholesterol and triglyceride levels also modify their response to a lifestyle intervention in the setting of obesity and type-2 diabetes mellitus?: The Action for Health in Diabetes (Look AHEAD) study
Gordon S Huggins, George D Papandonatos, Bahar Erar, et al.
Obesity (Silver Spring, Md.)
|
April 29, 2014
Evaluation of early weight loss thresholds for identifying nonresponders to an intensive lifestyle intervention
Jessica L Unick, Patricia E Hogan, Rebecca H Neiberg, et al.
The Journal of Sexual Medicine
|
February 5, 2009
Erectile dysfunction in type 2 diabetic men: relationship to exercise fitness and cardiovascular risk factors in the Look AHEAD trial
Raymond C Rosen, Rena R Wing, Stephen Schneider, et al.
JAMA
|
January 5, 2013
Association of an intensive lifestyle intervention with remission of type 2 diabetes
Edward W Gregg, Haiying Chen, Lynne E Wagenknecht, et al.
The Journal of Clinical Endocrinology and Metabolism
|
March 17, 2016
Diabetes Incidence and Glucose Tolerance after Termination of Pioglitazone Therapy: Results from ACT NOW
Devjit Tripathy, Dawn C Schwenke, MaryAnn Banerji, et al.
Diabetes Care
|
April 8, 2014
Baseline adiponectin levels do not influence the response to pioglitazone in ACT NOW
Devjit Tripathy, Stephen C Clement, Dawn C Schwenke, et al.
Page
of 8